Evaluation of anti-sleeping-sickness drugs and topoisomerase inhibitors in combination on Trypanosoma brucei

The trypanocidal activities of combinations of anti-human African trypanosomiasis drugs (eornithine, melarsoprol, pentamidine and suramin), DNA topoisomerase I inhibitors [topotecan and 7-ethyl-10-hydroxycamptothecin (SN-38; the active compound of irinotecan)] and DNA topoisomerase II inhibitors (ac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of antimicrobial chemotherapy 2009-06, Vol.63 (6), p.1293-1295
Hauptverfasser: Steverding, Dietmar, Wang, Xia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1295
container_issue 6
container_start_page 1293
container_title Journal of antimicrobial chemotherapy
container_volume 63
creator Steverding, Dietmar
Wang, Xia
description The trypanocidal activities of combinations of anti-human African trypanosomiasis drugs (eornithine, melarsoprol, pentamidine and suramin), DNA topoisomerase I inhibitors [topotecan and 7-ethyl-10-hydroxycamptothecin (SN-38; the active compound of irinotecan)] and DNA topoisomerase II inhibitors (aclarubicin, daunorubicin, doxorubicin, epirubicin, idarubicin and mitoxantrone) against bloodstream forms of Trypanosoma brucei cultured in vitro were investigated. Results suggest that the combination of eornithine and mitoxantrone could be a potential alternative treatment for HAT.
doi_str_mv 10.1093/jac/dkp120
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_21012361</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/jac/dkp120</oup_id><sourcerecordid>1710171381</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-f0164563890b740375217020f5ec51e958269da14e02516cbb0cf5ac4f34cd263</originalsourceid><addsrcrecordid>eNp90U1rFTEUBuAgir2tbvwBMgi6EMaefN9ZammtUnBhleImZDKZmntnkjFnRtp_b2QuCi5c5UAeXg7nJeQZhTcUGn66s-6020-UwQOyoUJBzaChD8kGOMhaC8mPyDHiDgCUVNvH5Ig2nCsh5YYM5z_tsNg5pFilvrJxDjUO3k8h3tYY3D56xKrLyy2Wz66a05QCptFni74K8Xtow5wylrFyaWxDPGTF6jrfTzamgm3V5sX58IQ86u2A_unhPSFfLs6vzy7rq0_vP5y9vaqdEHque6BlOcW3DbRaANeSUQ0MeumdpL6RW6aazlLhgUmqXNuC66V1oufCdUzxE_JqzZ1y-rF4nM0Y0PlhsNGnBQ2jQBlXtMAX_8BdWnIsuxWj1ZaD1gW9XpHLCTH73kw5jDbfGwrmdwGmFGDWAgp-fkhc2tF3f-nh4gW8XEFapv8H1asLOPu7P9LmvVG6nMRc3nwzny_Y13cfb6QR_Bee6Z4f</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217683077</pqid></control><display><type>article</type><title>Evaluation of anti-sleeping-sickness drugs and topoisomerase inhibitors in combination on Trypanosoma brucei</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Steverding, Dietmar ; Wang, Xia</creator><creatorcontrib>Steverding, Dietmar ; Wang, Xia</creatorcontrib><description>The trypanocidal activities of combinations of anti-human African trypanosomiasis drugs (eornithine, melarsoprol, pentamidine and suramin), DNA topoisomerase I inhibitors [topotecan and 7-ethyl-10-hydroxycamptothecin (SN-38; the active compound of irinotecan)] and DNA topoisomerase II inhibitors (aclarubicin, daunorubicin, doxorubicin, epirubicin, idarubicin and mitoxantrone) against bloodstream forms of Trypanosoma brucei cultured in vitro were investigated. Results suggest that the combination of eornithine and mitoxantrone could be a potential alternative treatment for HAT.</description><identifier>ISSN: 0305-7453</identifier><identifier>EISSN: 1460-2091</identifier><identifier>DOI: 10.1093/jac/dkp120</identifier><identifier>PMID: 19336455</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Animals ; Antimicrobial agents ; Antiprotozoal Agents - pharmacology ; Chemotherapy ; DNA topoisomerase inhibitors ; drug combinations ; Drug Synergism ; Enzyme Inhibitors - pharmacology ; Humans ; Inhibitor drugs ; Inhibitory Concentration 50 ; Parasitic diseases ; Parasitic Sensitivity Tests ; Pharmacology ; T. brucei ; Trypanosoma brucei ; Trypanosoma brucei brucei - drug effects</subject><ispartof>Journal of antimicrobial chemotherapy, 2009-06, Vol.63 (6), p.1293-1295</ispartof><rights>The Author 2009. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org 2009</rights><rights>The Author 2009. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-f0164563890b740375217020f5ec51e958269da14e02516cbb0cf5ac4f34cd263</citedby><cites>FETCH-LOGICAL-c447t-f0164563890b740375217020f5ec51e958269da14e02516cbb0cf5ac4f34cd263</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1584,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19336455$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Steverding, Dietmar</creatorcontrib><creatorcontrib>Wang, Xia</creatorcontrib><title>Evaluation of anti-sleeping-sickness drugs and topoisomerase inhibitors in combination on Trypanosoma brucei</title><title>Journal of antimicrobial chemotherapy</title><addtitle>J Antimicrob Chemother</addtitle><description>The trypanocidal activities of combinations of anti-human African trypanosomiasis drugs (eornithine, melarsoprol, pentamidine and suramin), DNA topoisomerase I inhibitors [topotecan and 7-ethyl-10-hydroxycamptothecin (SN-38; the active compound of irinotecan)] and DNA topoisomerase II inhibitors (aclarubicin, daunorubicin, doxorubicin, epirubicin, idarubicin and mitoxantrone) against bloodstream forms of Trypanosoma brucei cultured in vitro were investigated. Results suggest that the combination of eornithine and mitoxantrone could be a potential alternative treatment for HAT.</description><subject>Animals</subject><subject>Antimicrobial agents</subject><subject>Antiprotozoal Agents - pharmacology</subject><subject>Chemotherapy</subject><subject>DNA topoisomerase inhibitors</subject><subject>drug combinations</subject><subject>Drug Synergism</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Humans</subject><subject>Inhibitor drugs</subject><subject>Inhibitory Concentration 50</subject><subject>Parasitic diseases</subject><subject>Parasitic Sensitivity Tests</subject><subject>Pharmacology</subject><subject>T. brucei</subject><subject>Trypanosoma brucei</subject><subject>Trypanosoma brucei brucei - drug effects</subject><issn>0305-7453</issn><issn>1460-2091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90U1rFTEUBuAgir2tbvwBMgi6EMaefN9ZammtUnBhleImZDKZmntnkjFnRtp_b2QuCi5c5UAeXg7nJeQZhTcUGn66s-6020-UwQOyoUJBzaChD8kGOMhaC8mPyDHiDgCUVNvH5Ig2nCsh5YYM5z_tsNg5pFilvrJxDjUO3k8h3tYY3D56xKrLyy2Wz66a05QCptFni74K8Xtow5wylrFyaWxDPGTF6jrfTzamgm3V5sX58IQ86u2A_unhPSFfLs6vzy7rq0_vP5y9vaqdEHque6BlOcW3DbRaANeSUQ0MeumdpL6RW6aazlLhgUmqXNuC66V1oufCdUzxE_JqzZ1y-rF4nM0Y0PlhsNGnBQ2jQBlXtMAX_8BdWnIsuxWj1ZaD1gW9XpHLCTH73kw5jDbfGwrmdwGmFGDWAgp-fkhc2tF3f-nh4gW8XEFapv8H1asLOPu7P9LmvVG6nMRc3nwzny_Y13cfb6QR_Bee6Z4f</recordid><startdate>20090601</startdate><enddate>20090601</enddate><creator>Steverding, Dietmar</creator><creator>Wang, Xia</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope></search><sort><creationdate>20090601</creationdate><title>Evaluation of anti-sleeping-sickness drugs and topoisomerase inhibitors in combination on Trypanosoma brucei</title><author>Steverding, Dietmar ; Wang, Xia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-f0164563890b740375217020f5ec51e958269da14e02516cbb0cf5ac4f34cd263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Antimicrobial agents</topic><topic>Antiprotozoal Agents - pharmacology</topic><topic>Chemotherapy</topic><topic>DNA topoisomerase inhibitors</topic><topic>drug combinations</topic><topic>Drug Synergism</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Humans</topic><topic>Inhibitor drugs</topic><topic>Inhibitory Concentration 50</topic><topic>Parasitic diseases</topic><topic>Parasitic Sensitivity Tests</topic><topic>Pharmacology</topic><topic>T. brucei</topic><topic>Trypanosoma brucei</topic><topic>Trypanosoma brucei brucei - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Steverding, Dietmar</creatorcontrib><creatorcontrib>Wang, Xia</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of antimicrobial chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Steverding, Dietmar</au><au>Wang, Xia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of anti-sleeping-sickness drugs and topoisomerase inhibitors in combination on Trypanosoma brucei</atitle><jtitle>Journal of antimicrobial chemotherapy</jtitle><addtitle>J Antimicrob Chemother</addtitle><date>2009-06-01</date><risdate>2009</risdate><volume>63</volume><issue>6</issue><spage>1293</spage><epage>1295</epage><pages>1293-1295</pages><issn>0305-7453</issn><eissn>1460-2091</eissn><abstract>The trypanocidal activities of combinations of anti-human African trypanosomiasis drugs (eornithine, melarsoprol, pentamidine and suramin), DNA topoisomerase I inhibitors [topotecan and 7-ethyl-10-hydroxycamptothecin (SN-38; the active compound of irinotecan)] and DNA topoisomerase II inhibitors (aclarubicin, daunorubicin, doxorubicin, epirubicin, idarubicin and mitoxantrone) against bloodstream forms of Trypanosoma brucei cultured in vitro were investigated. Results suggest that the combination of eornithine and mitoxantrone could be a potential alternative treatment for HAT.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>19336455</pmid><doi>10.1093/jac/dkp120</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0305-7453
ispartof Journal of antimicrobial chemotherapy, 2009-06, Vol.63 (6), p.1293-1295
issn 0305-7453
1460-2091
language eng
recordid cdi_proquest_miscellaneous_21012361
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection; Free Full-Text Journals in Chemistry
subjects Animals
Antimicrobial agents
Antiprotozoal Agents - pharmacology
Chemotherapy
DNA topoisomerase inhibitors
drug combinations
Drug Synergism
Enzyme Inhibitors - pharmacology
Humans
Inhibitor drugs
Inhibitory Concentration 50
Parasitic diseases
Parasitic Sensitivity Tests
Pharmacology
T. brucei
Trypanosoma brucei
Trypanosoma brucei brucei - drug effects
title Evaluation of anti-sleeping-sickness drugs and topoisomerase inhibitors in combination on Trypanosoma brucei
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T18%3A20%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20anti-sleeping-sickness%20drugs%20and%20topoisomerase%20inhibitors%20in%20combination%20on%20Trypanosoma%20brucei&rft.jtitle=Journal%20of%20antimicrobial%20chemotherapy&rft.au=Steverding,%20Dietmar&rft.date=2009-06-01&rft.volume=63&rft.issue=6&rft.spage=1293&rft.epage=1295&rft.pages=1293-1295&rft.issn=0305-7453&rft.eissn=1460-2091&rft_id=info:doi/10.1093/jac/dkp120&rft_dat=%3Cproquest_cross%3E1710171381%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=217683077&rft_id=info:pmid/19336455&rft_oup_id=10.1093/jac/dkp120&rfr_iscdi=true